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Abstract 
Sulfonamide substituted 8-hydroxyquinoline derivatives were prepared using a 
microwave synthesizer. The interaction of sulfonamide substituted 8-hydroxy-
quinoline derivatives and their transition metal complexes with Plasmid 
(pUC 19) DNA and Calf Thymus DNA were investigated by UV spectroscopic 
studies and gel electrophoresis measurements. The interaction between 
ligand/metal complexes and DNA was carried out by increasing the 
concentration of DNA from 0 to 12 µl in UV spectroscopic study, while the 
concentration of DNA in gel electrophoresis remained constant at 10 µl. These 
studies supported the fact that, the complex binds to DNA by intercalation via 
ligand into the base pairs of DNA. The relative binding efficacy of the complexes 
to DNA was much higher than the binding efficacy of ligands, especially the 
complex of Cu-AHQMBSH had the highest binding ability to DNA. The mobility 
of the bands decreased as the concentration of the complex was increased, 
indicating that there was increase in the interaction between the metal ion and 
DNA. Complexes of AHQMBSH were excellent for DNA binding as compared to 
HQMABS. 
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Introduction 
DNA is often referred as the molecule of heredity, as it is responsible for the genetic 
propagation of all traits [1–3]. Over the past decades, there has been a considerable 
interest in DNA binding properties towards different types of metal complexes. Further, 
many transition metal complexes have been used as tools for understanding DNA 
structure, as agents for mediation of DNA cleavage or as a chemotherapeutic agents. DNA 
is a significant cellular receptor, many chemicals bring to bear their antitumor effects by 
binding to DNA and by this means changes the replication of DNA and inhibits the growth 
of the tumor cells, which is the basis of designing new and more efficient antitumor drugs. 
Moreover, their effectiveness depends on the mode and affinity of their binding ability to 
the DNA strands [4–6]. A number of metal chelates, as agents for mediation of strand 
scission of duplex DNA and as chemotherapeutic agents, have been used as probes of 
DNA structure in solution [7–9]. 
8-Hydroxyquinoline (8HQ) and its derivatives have attracted unique interest for basic 
research and practical applications due to their therapeutic properties. 8-Hydroxyquinoline 
inhibits rapidly and selectively the RNA synthesis in yeast [10]. Iron bound to the lipophilic 
chelator 8HQ, causes substantial DNA strand breakage of cultured human lung cells [11]. 
Many quinoline and their derivatives have been used in the treatment of cancer, 
tuberculosis, diabetes, malaria, and convulsion [12–15]. In medicine particularly, a new 
class of drugs have been reported as potent HIV-1 inhibitors [16,  17], protein tyrosine 
kinase inhibitors [18], protozoal–retroviral co-infections [19], anti-HIV-1 agents [20] and 
therapeutic drugs for the inflammatory diseases [21]. Moreover, 8-hydroxyquinoline 
derivatives are also potent agents for neuro protection in Alzheimer's, Parkinson's, and 
other neuro degenerative diseases [22]. Other important applications of 8-hydroxy-
quinoline derivatives have been used extensively to construct highly sensitive fluorescent 
chemosensors for sensing and imaging of metal ions of important biological and 
environmental significance [23–25]. On the other hand, an excess of activated oxygen 
species in the forms of superoxide anion (O2
−) and hydroxyl radical (OH
−), generated by 
normal metabolic processes, may cause various diseases such as carcinogenesis, drug-
associated toxicity, inflammation, parthenogenesis and aging in aerobic organisms   
[26–28]. More specifically, 8-hydroxyquinoline moiety has been mostly used for its capacity 
to strongly chelate metal ions, particularly Cu
+2 and Zn
+2 [29].  
Looking to the above importance of DNA binding study of 8-hydroxyquinoline and in 
continuation of our earlier work [30, 31], the present paper describes microwave assisted 
synthesis and DNA binding interaction assay of sulfonamides substituted 8-hydroxy-
quinoline derivatives. 
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Experimental 
Chemicals 
Plasmid (pUC 19) DNA and Calf Thymus (CT) DNA were purchased from Sigma-Aldrich 
Chemicals Pvt. Ltd., India. All solvents and reagents were purchased commercially from 
Hi-Media Laboratories Pvt. Ltd., India, and were used without further purification. A 
solution of DNA in the buffer (Phosphate, pH 7.0) gave a ratio of UV absorbance at 260 
and 280 nm of about 1.90 indicating that the DNA was sufficiently free of protein [32,33]. 
The CT-DNA concentrations in terms of base pair L
−1 and in terms of nucleotide L
−1 were 
determined spectrophotometrically by employing an extinction coefficient of 13,200 M
−1 
cm
−1 (base pair) 
−1 and 6600 M
−1 cm
−1 (nucleotide) 
−1 at 260 nm, respectively [34]. Micro-
wave experiments were carried out at atmospheric pressure in a glass vessel prolonged 
by a condenser, using a scientific microwave reactor (700 W Catalyst
TM Systems, Model: 
Cata-R). 
Microwave assisted procedure for the synthesis of HQMABS 
(4-{[(8-hydroxyquinolin-5-yl)methyl]amino}benzenesulfonamide) 
A mixture of 4-aminobenzenesulfonamide (0.02 mol), 5-(chloromethyl)-8-hydroxyquinoline 
hydrochloride (0.022 mol) and triethylamine (0.04 mol) in acetonitrile (3 mL) contained in a 
two-neck round bottomed flask fitted with a device condenser was heated under 
microwave irradiation at 350 W. After 4 minutes of microwave irradiation, the reaction was 
completed (Scheme 1), which was confirmed by TLC (chloroform : methanol : ammonia 
(70:29:1)). The reaction mixture was then poured into ice-cold water to afford off-white 
solid, which was filtered, washed with hot water, recrystallized from ethanol and dried 
under vacuum to obtain colorless crystals of HQMABS. Yield = 92.8%; mp 287  °C 
(identical to the product obtained in ref. [30]). MS (m/z) 330.0 (M+1) for C16H15N3O3S 
(329.4). FT-IR (KBr), ν, cm
−1: 3401, 1401 (O–H); 3200 (N–H); 2864 (–CH2–), 1599 (C=N), 
1144 (S=O), 1098 (C–O–H). 
1H NMR (400 MHz, DMSO-d6, TMS): δ 9.73 (bs, 1H, OH), 
8.89 (d, J = 8.4 Hz, 1H, H2), 7.62 (d, J = 8.4 Hz, 1H, H3), 8.50 (d, J = 8.4 Hz, 1H, H4), 
7.45 (d, J = 8.0 Hz, 1H, H6), 7.05 (d, J = 8.0 Hz, 1H, H7), 7.52 (d, J = 8.8 Hz, 2H, H14), 
6.87 (d, J = 8.8 Hz, 2H, H13),6.92 (bs, 2H, SO2NH2), 6.87 (t, J = 5.2 Hz, 1H, C-NH), 4.66 
(d, J = 5.2 Hz, 2H, CH2-N). 
13C NMR (100 MHz, DMSO-d6, TMS): δ 153.17 (C12), 151.79 
(C8), 148.36 (C2), 139.29 (C10), 133.16 (C4), 130.72 (C15), 129.61 (C9), 127.74 (C14), 
127.41 (C6), 124.73 (C5), 122.26 (C3), 111.52 (C13), 110.67 (C7), 43.98 (C11). 
Microwave assisted procedure for the synthesis of the AHQMBSH 
(4-amino-N'-[(8-hydroxyquinolin-5-yl)methyl]benzenesulfonohydrazide) 
A mixture of 4-acetamidobenzenesulfonyl hydrazide  (0.02 mol), 5-(chloromethyl)-
8-hydroxyquinoline hydrochloride (0.022 mol) and triethylamine (0.04 mol) in dry pyridine 
(3 mL) contained in a two-neck round bottomed flask fitted with a device condenser was 
heated under microwave irradiation at 350 W for 1 min. The product formation was 
monitored by TLC (CHCl3 : CH3OH (80 : 20)). The excess pyridine was distilled off and the 
residue was poured into the ice-cold water to yield a dark orange product which was 
filtered and washed with hot water and ethyl acetate and then dried over a vacuum 
desiccator. It was further hydrolyzed by treatment with solution of 10 % HCl (5 ml) and 
ethanol (1 ml) using microwave irradiation at 245 W for 3 min (Scheme 1). The reaction 
mixture was then cooled, poured into ice-cold water and neutralized with saturated 
NaHCO3 solution to yield a dark green product, which was filtered off, washed with hot-296  R. B. Dixit et al.:  
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water and recrystallized from acetonitrile to afford dark green crystals, and was dried in a 
vacuum oven. Yield: 72%. Decomposed at 241 °C (identical to the product obtained in ref. 
[30]); MS (m/z) 344.02 (M+1) for C16H16N4O3S (344.39). FT-IR (KBr), ν, cm
−1: 3339, 1400 
(O–H); 3200 (N–H); 2964 (–CH2–), 1598 (C=N), 1318, 1144 (S=O), 1101 (C–O–H), 1036 
(N–N). 
1H NMR (400 MHz, DMSO-d6, TMS): δ 12.48 (s, 1H, SO2NH), 10.74 (s, 1H, NHC), 
9.99 (bs, 1H, OH), 8.83 (d, J = 8.0 Hz, 1H, H2), 7.51 (d, J = 8.0 Hz, 1H, H3), 8.46 (d, J = 
8.0 Hz, 1H, H4), 7.20 (d, J = 7.6 Hz, 1H, H6), 7.02 (d, J = 7.6 Hz, 1H, H7), 7.24 (d, J = 8.4 
Hz, 2H, H14), 6.52 (d, J = 8.4 Hz, 2H, H13), 6.14 (bs, 2H, NH2), 4.87 (s, 2H, CH2-N). 
13C 
NMR (100 MHz, DMSO-d6, TMS): δ 154.06 (C15), 153.09 (C8), 148.13 (C2), 138.53 (C10), 
134.50 (C4), 132.47 (C6), 130.48 (C13), 128.51 (C12), 123.43 (C9), 122.01 (C3), 116.40 (C5), 
112.90 (C14), 110.04 (C7), 58.27 (C11). 
 
Sch. 1.   Microwave assisted synthesis of HQMABS and AHQMBSH. 
Synthesis of complexes  
Transition metal complexes of sulfonamides substituted 8-hydroxyquinoline derivatives 
[4-amino-N'-[(8-hydroxyquinolin-5-yl)methyl]benzenesulfonohydrazide (AHQMBSH) and 
4-{[(8-hydroxyquinolin-5-yl)methyl]amino}benzenesulfonamide (HQMABS)] as shown in 
Figure 1, were synthesized by the method reported in our previous articles [30, 31].   DNA-Binding Interaction Studies of 8-Hydroxyquinoline Derivatives  297 
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Fig. 1.   Structure of metal complexes. 
Methods and Measurements 
The DNA-binding experiments were performed [35–37] at room temperature for ligands 
and its transition metal complexes. The solutions were prepared in DMSO at 10 μM 
concentration. 
UV–Visible experiment 
UV–Visible spectra were recorded on a Shimadzu UV-Visible Spectrophotometer (Japan). 
UV absorption spectra were studied in the absence and in the presence of DNA (pUC 19 
and Calf Thymus) at a constant concentration of the ligand and complexes (10 µM) in 
phosphate buffer (pH 7.0). For that, the appropriate volume of the ligand/complex (10 μl) 
and solution of 0-12 μl DNA (pUC 19 and Calf Thymus) were added in the phosphate 
buffer by maintaining the pH of the solutions at 7.0.  
Gel electrophoresis experiment 
For the gel electrophoresis experiments, DNA (pUC 19 and Calf Thymus) was treated with 
ligand/metal complexes in phosphate buffer at pH 7.0. Agarose gel (0.8 % w/v) was 
prepared in TBE buffer (45 mM Tris, 45 mM boric acid and 1 mM EDTA, pH 7.3). Then 10 
μl each of the incubated ligand/metal complex and DNA mixture was incubated at room 
temperature for 2 h. then it was loaded on the gel with tracking dye (0.25% bromophenol 
blue, 40% sucrose, 0.25% xylene cyanole, and 200 mM EDTA) and electrophoresis was 
carried out under TBE buffer system at 50 V for run. At the end of electrophoresis i.e. the 
end of DNA migration, the electric current was turned off. Then, the gel was stained by 
immersing it in water containing ethidium bromide (0.5 μg/ml) for 30–45 min at room 
temperature and later visualized under UV light using a transilluminator. The illuminated 
gel images were captured with an attached camera. Photo quantization of the gel after 
electrophoresis was estimated using AlphaDigiDoc
TM RT. Version V.4.0.0 PC–Image 
software, California (USA).  
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Results and Discussion 
UV absorption spectroscopic titration  
Absorption titration was carried out to monitor the interaction of a compound with DNA. 
The interaction of the ligands/transition metal complexes with DNA (pUC 19 and Calf 
Thymus) was investigated using the UV absorption spectra of complex in the absence and 
presence of increasing concentration of DNA and at a constant concentration of the 
complexes (10 µl). The observable hypochromism and red shift are usually characterized 
by the non-covalently intercalative binding of compound to DNA helix, due to the strong 
stacking interaction between the aromatic chromophore of the compound and base pairs 
of DNA [38, 39]. The DNA binding data of ligands/complexes were represented in Tables 1 
and 2. Results of absorption titration for pUC 19 DNA as well as CT-DNA showed that no 
major difference was observed in the value of λmax. Figures 2 and 3 represent the 
absorption spectra of complex in the absence and presence of increasing amounts of 
DNA. In the UV region, the intense absorption bands were observed due to the metal 
complex, which is believed to be the band of intraligand transition of the coordinated 
groups. An addition of increasing amounts of the DNA resulted in hypochromism and 
bathochromic shift in the UV spectra. The hypochromism in the intraligand band reaches 
as high as at around 286.9 nm and 276.2 nm with red shift at the ratio of [DNA]/[Cu] in 
case of Cu-AHQMBSH and Cu-HQMABS respectively. These spectral characteristics 
suggest that the complexes had been bound to the base pairs DNA by intercalation. This 
bathochromism result might be due to the decrease in the energy of π→π* transition, 
when the π - orbital of the base pairs of DNA coupled with the π→π* orbital of the 
intercalated ligand.  
 
Fig. 2.   Absorption spectra of Cu-AHQMBSH complex in absence and presence of 
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Fig. 3.   Absorption spectra of Cu-HQMABS complex in absence and presence of 
Plasmid DNA. 
Tab. 1.   Absorption titration data of ligands and complexes with Plasmid DNA. 
Complex DNA 
(µl) 
Complex λmax
(nm) 
Ligand λmax
(nm) 
M(II) λmax 
(nm) 
Mn-AHQMBSH 0  282.8  263.2  271.2 
 4  278.1  261.6  267.2 
 8  269.4  259.4  265.6 
 12  267.6  258.1  264.9 
Fe-AHQMBSH 0  283.9  262.7  270.9 
 4  276.2  259.8  267.6 
 8  268.7  259.1  265.7 
 12  267.4  258.3  264.2 
Co-AHQMBSH 0  284.9  262.9  271.4 
 4  282.0  260.1  268.3 
 8  269.8  259.7  266.5 
 12  267.5  258.4  264.6 
Ni-AHQMBSH 0  280.4  262.9  270.8 
 4  279.6  260.7  266.9 
 8  270.1  258.7  264.7 
 12  268.0  258.1  257.8 
Cu-AHQMBSH 0  286.9  263.4  271.6 
 4  280.2  262.0  267.9 
 8  270.7  258.9  265.8 
 12  268.3  257.1  263.9 
Zn-AHQMBSH 0  282.1  263.4  270.9 
 4  276.0  262.6  266.6 
 8  261.4  259.1  265.0 
 12  267.9  258.0  264.0 
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Tab. 1.   (Cont.) 
Complex DNA 
(µl) 
Complex λmax
(nm) 
Ligand λmax
(nm) 
M(II) λmax 
(nm) 
Mn-HQMABS 0  273.8  261.9  269.1 
 4  268.6  260.5  266.0 
 8  260.3  258.2  259.4 
 12  258.2  257.7  257.9 
Fe-HQMABS 0  274.0  261.2  268.8 
 4  266.8  259.4  266.1 
 8  259.7  258.2  259.2 
 12  257.2  257.7  257.7 
Co-HQMABS 0  275.8  262.0  268.1 
 4  271.2  260.6  265.6 
 8  259.4  258.3  259.4 
 12  258.6  257.8  256.8 
Ni-HQMABS 0  270.6  262.6  268.4 
 4  269.2  260.4  266.3 
 8  259.8  258.7  259.0 
 12  258.1  257.3  257.8 
Cu-HQMABS 0  276.2  261.7  269.2 
 4  269.8  260.4  266.7 
 8  263.4  258.6  259.5 
 12  258.6  257.2  257.9 
Zn-HQMABS 0  272.3  263.8  268.9 
 4  265.6  262.1  265.8 
 8  259.2  259.4  259.2 
 12  257.9  255.3  257.8 
 
Tab. 2.   Absorption titration data of ligands and complexes with CT DNA. 
Complex DNA 
(µl) 
Complex λmax
(nm) 
Ligand λmax
(nm) 
M(II) λmax 
(nm) 
Mn-AHQMBSH 0  284.8  263.2  271.3 
 4  279.3  261.6  267.4 
 8  269.9  259.4  265.9 
 12  266.8  257.9  264.2 
Fe-AHQMBSH 0  285.9  262.9  271.0 
 4  277.8  259.4  267.9 
 8  270.7  258.7  266.5 
 12  268.6  258.1  264.9 
Co-AHQMBSH 0  286.2  262.9  271.9 
 4  284.1  260.1  268.6 
 8  270.6  259.7  266.5 
 12  268.3  258.4  264.3 
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Tab. 2.   (Cont.) 
Complex DNA 
(µl) 
Complex λmax
(nm) 
Ligand λmax
(nm) 
M(II) λmax 
(nm) 
Ni-AHQMBSH 0  282.1  262.4  271.2 
 4  280.5  260.8  267.9 
 8  273.0  258.9  266.4 
 12  268.7  258.0  264.6 
Cu-AHQMBSH 0  286.2  263.1  271.8 
 4  281.5  261.8  267.7 
 8  273.3  258.6  266.3 
 12  269.7  257.9  263.9 
Zn-AHQMBSH 0  283.8  263.6  271.5 
 4  277.2  261.3  267.1 
 8  263.4  259.4  265.0 
 12  258.3  257.9  264.2 
Mn-HQMABS 0  272.9  262.0  268.8 
 4  268.1  260.8  266.0 
 8  260.0  258.2  259.1 
 12  257.6  257.1  257.0 
Fe-HQMABS 0  274.0  261.4  268.8 
 4  266.6  259.4  266.1 
 8  259.3  258.6  259.4 
 12  257.2  257.7  257.7 
Co-HQMABS 0  274.9  261.7  268.0 
 4  271.0  260.2  265.3 
 8  259.2  258.1  259.0 
 12  258.5  257.6  256.9 
Ni-HQMABS 0  271.2  262.8  268.5 
 4  269.5  260.7  266.5 
 8  259.9  258.8  259.0 
 12  258.3  257.5  257.6 
Cu-HQMABS 0  275.9  261.5  269.0 
 4  269.4  260.1  266.3 
 8  263.0  258.1  259.6 
 12  258.2  257.1  257.8 
Zn-HQMABS 0  271.8  263.2  268.4 
 4  265.1  262.4  265.2 
 8  258.7  259.7  259.0 
 12  257.5  255.1  257.4 
 
Gel electrophoresis  
The interaction of ligands/transition metal complexes with DNA was studied by 
electrophoresis and the results were represented in Figures 4 to 7 (Lane 3–8, are DNA + 
metal complex; lane 1, 2 were untreated DNA and DNA + ligand). In this study, DNA was 
allowed to interact with the ligands/metal complexes in presence of TAE buffer at pH 7.3 in 
air. When DNA was subjected to the electrophoresis after interaction and upon illumination 302  R. B. Dixit et al.:  
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of gel (Figures 4 to 7), the fastest migration was observed for super coiled (SC) Form I, 
where as the slowest migration was observed for open circular (OC) Form III and the 
intermediate migration was the linear (LC) Form II generated on cleavage of open circular. 
The intensity of untreated DNA band (Lane  1) appeared as such even after 
electrophoresis. Furthermore, the DNA cleavage data showed that the complexes Ni-
AHQMBSH, Cu-AHQMBSH, Zn-AHQMBSH, Cu-HQMABS and Zn-HQMABS showed 
maximum cleavage ability compared to all the compounds (Tables 3 and 4). The variation 
in DNA–cleavage efficiency of ligands/transition metal complexes was due to their 
difference in binding ability of ligands/complexes to DNA. The intensity of lane 6, 7 and 8 
were higher than others in AHQMBSH-complexes (Figures 4 and 6), which indicated that 
complex of Ni(II), Cu(II) and Zn(II) showed more strong binding ability with DNA. However, 
in case of HQMABS-complexes (Figures 5 and 7), all metal complexes showed moderate 
binding with DNA. The relative binding efficacy of the complexes to DNA was much higher 
than the ligands, and among the complexes, the binding efficacy for complexes of 
AHQMBSH were better than that of HQMABS-complexes. Among, the tested compounds, 
Cu-AHQMBSH was found to have excellent binding ability for DNA.  
 
Fig. 4.   DNA binding results of ligands and metal complexes based on Gel 
electrophoresis. 
Lane 1: Plasmid (pUC 19) DNA    Lane 2: pUC 19 + AHQMBSH 
Lane 3: pUC 19 + Mn-AHQMBSH    Lane 4: pUC 19 + Fe-AHQMBSH 
Lane 5: pUC 19 + Co-AHQMBSH    Lane 6: pUC 19 + Ni-AHQMBSH 
Lane 7: pUC 19 + Cu-AHQMBSH    Lane 8: pUC 19 + Zn-AHQMBSH 
 
 
Fig. 5.   DNA binding results of ligands and metal complexes based on Gel 
electrophoresis. 
Lane 1: Plasmid (pUC 19) DNA    Lane 2: pUC 19 + HQMABS 
Lane 3: pUC 19 + Mn-HQMABS    Lane 4: pUC 19 + Fe-HQMABS 
Lane 5: pUC 19 + Co-HQMABS    Lane 6: pUC 19 + Ni-HQMABS 
Lane 7: pUC 19 + Cu-HQMABS    Lane 8: pUC 19 + Zn-HQMABS 
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Tab. 3.   DNA cleavage data by gel electrophoresis for AHQMBSH and their metal 
complexes 
Plasmid-DNA CT-DNA  Lane No.  Compound 
SC % OC % LC % SC % OC %  LC %
1 DNA  100  –  –  100  –  – 
2 AHQMBSH  41  44  15  43  46  11 
3 Mn-AHQMBSH  39  46  15  39  45  16 
4 Fe-AHQMBSH  45  44  11  42  43  15 
5 Co-AHQMBSH  43  48  09  41  47  12 
6 Ni-AHQMBSH  17  42  41  43  46  11 
7 Cu-AHQMBSH  12  41  47  21  37  42 
8 Zn-AHQMBSH  51  36  13  22  32  46 
 
 
Fig. 6.   DNA binding results of ligands and metal complexes based on Gel 
electrophoresis. 
Lane 1: CT - DNA        Lane 2: CT - DNA + AHQMBSH 
Lane 3: CT - DNA + Mn-AHQMBSH   Lane 4: CT - DNA + Fe-AHQMBSH 
Lane 5: CT - DNA + Co-AHQMBSH   Lane 6: CT - DNA + Ni-AHQMBSH 
Lane 7: CT - DNA + Cu-AHQMBSH   Lane 8: CT - DNA + Zn-AHQMBSH 
 
 
Fig. 7.   DNA binding results of ligands and metal complexes based on Gel 
electrophoresis. 
Lane 1: CT - DNA        Lane 2: CT - DNA + HQMABS 
Lane 3: CT - DNA + Mn-HQMABS    Lane 4: CT - DNA + Fe-HQMABS 
Lane 5: CT - DNA + Co-HQMABS    Lane 6: CT - DNA + Ni-HQMABS 
Lane 7: CT - DNA + Cu-HQMABS    Lane 8: CT - DNA + Zn-HQMABS 
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Tab. 4.   DNA cleavage data by gel electrophoresis for HQMABS and their metal 
complexes  
Plasmid-DNA CT-DNA  Lane No.  Compound 
SC % OC % LC % SC % OC %  LC %
1  DNA  100 –  – 100 –  – 
2  HQMABS  81 19  – 78 22  – 
3  Mn-HQMABS  74 26  – 76 24  – 
4  Fe-HQMABS 77 23  – 71 29  – 
5  Co-HQMABS 86 14  – 83 17  – 
6  Ni-HQMABS  79 21  – 77 23  – 
7  Cu-HQMABS 63 37  – 71 29  – 
8  Zn-HQMABS 78 22  – 69 31  – 
 
Conclusion 
The results of UV spectroscopy and electrophoresis measurement showed that metal 
complex binds with DNA via interaction as well as intercalation with the base pairs of DNA 
(pUC 19 and Calf Thymus). It also suggests that the covalent binding of the metal complex 
caused a change in the conformation of DNA such as more of intercalated and thus an 
increase in intensity of the band was generally observed. Moreover, the results described 
in this study showed that changing the ligand environment can modulate the binding 
property of the complex with DNA. The relative binding efficacy of the complexes to DNA 
was much higher than binding efficacy of ligands, especially the Cu-AHQMBSH complex 
has the highest binding ability to DNA, and complexes of AHQMBSH were better for DNA 
binding. 
Acknowledgement 
The authors gratefully acknowledge the financial support for this work by the TWAS 
(UNESCO FR: 08-025RG/CHE/AS), Italy. We are also thankful to authorities of C.V.M. 
and Director, ARIBAS, New Vallabh Vidyangar for providing necessary research facilities. 
We express thanks to Miss B. Kavita, Department of Bio-Sciences, Sardar Patel University 
for her valuable suggestions. 
Authors’ Statement 
Competing Interests 
The authors declare no conflict of interest. 
References 
[1]  Hannon MJ.  
Supramolecular DNA recognition.  
Chem Soc Rev. 2007; 36: 280–295.  
doi:10.1039/b606046n   DNA-Binding Interaction Studies of 8-Hydroxyquinoline Derivatives  305 
Sci Pharm. 2011; 79: 293–308 
[2]  MacMillan AM.  
Fifty years of "Watson-Crick".  
Pure Appl Chem. 2004; 76: 1521–1524.  
doi:10.1351/pac200476071521 
[3]  MacMillan AM.  
Chemistry of nucleic acids - Part 3 - Preface.  
Pure Appl Chem. 2004; 76: 1521–1524.  
doi:10.1351/pac200476071521 
[4]  Zeng YB, Yang N, Liu WS, Tang N.  
Synthesis, characterization and DNA-binding properties of La(III) complex of chrysin.  
J Inorg Biochem. 2003; 97: 258–264. 
doi:10.1016/S0162-0134(03)00313-1 
[5]  Pyle AM, Morii T, Barton JK.  
Probing Microstructures in Double-Helical DNA with Chiral Metal Complexes: Recognition of Changes 
in Base-Pair Propeller Twisting in Solution.  
J Am Chem Soc. 1990; 112: 9432–9434.  
doi:10.1021/ja00181a077 
[6]  Barton JK, Goldberg JM, Kumar CV, Turro NJ.  
Binding modes and base specificity of tris(phenanthroline)ruthenium(II) enantiomers with nucleic 
acids: tuning the stereoselectivity.  
J Am Chem Soc. 1986; 108: 2081–2088.  
doi:10.1021/ja00268a057 
[7]  Mahadevan S, Palaniandavar M.  
Spectroscopic and voltammetric studies of copper(II) complexes of bis(pyrid-2-yl)-di/trithia ligands 
bound to calf thymus DNA.  
Inorg Chim Acta 1997;254:291-302.  
doi:10.1016/S0020-1693(96)05175-4 
[8]  Lippar SJ.  
Platinum complexes: Probes of polynucleotide structure and antitumor drugs.  
Acc Chem Res. 1978; 11: 211–217.  
doi:10.1021/ar50125a006 
[9]  Hech SM.  
The chemistry of activated bleomycin.  
Acc Chem Res. 1986; 19: 383–391. 
doi:10.1021/ar00132a002 
[10]  Fraser RSS, Creanor J.  
Rapid and Selective Inhibition of RNA Synthesis in Yeast by 8-Hydroxyquinoline.  
Eur J Biochem. 1974; 46: 67–73.  
doi:10.1111/j.1432-1033.1974.tb03597.x 
[11]  Leanderson P, Tagesson C.  
Iron bound to the lipophilic iron chelator, 8-hydroxyquinoline, causes DNA strand breakage in cultured 
lung cells.  
Carcinogenesis. 1996; 17: 545–550.  
doi:10.1093/carcin/17.3.545 
[12]  El-Sonbati AZ, El-Bindary AA, Shoair AF, Younes RM.  
Stereochemistry of New Nitrogen Containing Heterocyclic Aldehyde. VII. Potentiometric, 
Conductometric and Thermodynamic Studies of Novel Quinoline Azodyes and Their Metal Complexes 
with Some Transition Metals.  
Chem Pharm Bull. 2001; 49: 1308–1313.  
doi:10.1248/cpb.49.1308 306  R. B. Dixit et al.:  
Sci Pharm. 2011; 79: 293–308 
[13]  Schmidt LH.  
Chemotherapy of the Drug-Resistant Malarias.  
Annu Rev Microbiol. 1969; 23: 427–454.  
doi:10.1146/annurev.mi.23.100169.002235 
[14]  El-Asmy AA, El-Sonbati AZ, Ba-Issa AA, Mounir M.  
Synthesis and properties of 7-formyl-8-hydroxyquinoline and its transition metal complexes. Transit 
Met Chem. 1990; 15: 222–225.  
doi:10.1007/BF01038379 
[15]  Novak I, Kovac B.  
UV photoelectron spectroscopic study of substituent effects in quinoline derivatives.  
J Org Chem. 2004; 69: 5005–5010.  
doi:10.1021/jo040154n 
[16]  Mekouar K, Mouscadet JF, Desmaele D.  
Styrylquinoline derivatives: a new class of potent HIV-1 integrase inhibitors that block HIV-1 replication 
in CEM cells.  
J Med Chem. 1998; 41: 2846–2857.  
doi:10.1021/jm980043e 
[17]  Ouali M, Laboulais C, Leh H.  
Modeling of the inhibition of retroviral integrases by styrylquinoline derivatives.  
J Med Chem. 2000; 43: 1949–1957.  
doi:10.1021/jm9911581 
[18]  Chen CS, Lai SY, Hsu PS, Tsai CY, Fang CW, Su MJ, Cheng FC, Kao CL, Chern JW.  
Design, synthesis and biological evaluation of heterocycle-conjugated styrene derivatives as protein 
tyrosine kinase inhibitors and free radical scavengers.  
Chin Pharm J (Taipei, Taiwan). 2002; 54: 353–374.  
[19]  Fakhfakh MA, Fournet A, Prina E.  
Synthesis and biological evaluation of substituted quinolines: potential treatment of protozoal and 
retroviral coinfections.  
Bioorg Med Chem. 2003; 11: 5013–5023.  
doi:10.1016/j.bmc.2003.09.007 
[20]  Storz T, Marti R, Meier R, Nury P, Roeder M, Zhang K.  
First safe and practical synthesis of 2-amino-8-hydroxyquinoline.  
Org Proc Res Dev. 2004; 8: 663–665.  
doi:10.1021/op049944p 
[21]  Sawada Y, Kayakiri H, Abe Y, Mizutani T, Inamura N, Asano M, Hatori C, Aramori I, Oku T, Tanaka H.  
Discovery of the first non-peptide full agonists for the human bradykinin b2 receptor incorporating 4-(2-
picolyloxy)quinoline and 1-(2-picolyl) benzimidazole frameworks.  
J Med Chem. 2004; 47: 2853–2863.  
doi:10.1021/jm030468n 
[22]  Zheng HL, Weiner LM, Bar-Am O, Epsztejn S, Ioav Cabantchik Z, Warshawsky A, Youdim MBH, 
Fridkin M.  
Design, synthesis, and evaluation of novel bifunctional ironchelators as potential agents for 
neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases.  
Bioorg Med Chem. 2005; 13: 773–783.  
doi:10.1016/j.bmc.2004.10.037 
[23]  Zhang H, Han LF, Zachariasse KA, Jiang YB.  
8-hydroxyquinoline benzoates as highly sensitive fluorescent chemosensors for transition metal ions.  
Org Lett. 2005; 7: 4217–4220.  
doi:10.1021/ol051614h   DNA-Binding Interaction Studies of 8-Hydroxyquinoline Derivatives  307 
Sci Pharm. 2011; 79: 293–308 
[24]  Song KC, Kim JS, Park SM, Chung KC, Ahn S, Chang SK.  
Fluorogenic Hg
2+-selective chemodosimeter derived from 8-hydroxyquinoline.  
Org Lett. 2006; 8: 3413–3416.  
doi:10.1021/ol060788b 
[25]  Heiskanen JP, Omar WAE, Ylikunnari MK, Haavisto KM, Juan MJ, Hormi OEO.  
Synthesis of 4-alkoxy-8-hydroxyquinolines.  
J Org Chem 2007;72:920-922.  
doi:10.1021/jo062175i 
[26]  Ames BN, Shigenaga MK, Hagen TM.  
Oxidants, antioxidants, and the degenerative diseases of aging.  
Proc Natl Acad Sci U S A. 1993; 90: 7915–7922.  
doi:10.1073/pnas.90.17.7915 
[27]  Horton AA, Fairhurst S.  
Lipid peroxidation and mechanisms of toxicity.  
Crit Rev Toxicol. 1987; 18: 27–79.  
doi:10.3109/10408448709089856 
[28]  Wang HL, Yang ZY, Wang BD.  
Synthesis, characterization and the antioxidative activity of copper(II), zinc(II) and nickel(II) complexes 
with naringenin.  
Transit Met Chem. 2006; 31: 470–474.  
doi:10.1007/s11243-006-0015-3 
[29]  Ji HF, Zhang HY.  
A new strategy to combat Alzheimer’s disease. Combining radical-scavenging potential with metal-
protein-attenuating ability in one molecule.  
Bioorg Med Chem Lett 2005;15:21-24.  
doi:10.1016/j.bmcl.2004.10.047 
[30]  Dixit RB, Vanparia SF, Patel TS, Jagani CL, Doshi HV, Dixit BC.  
Synthesis and antimicrobial activities of sulfonohydrazide substituted 8-hydroxyquinoline derivative 
and its oxinates.  
Appl Organometal Chem. 2010; 24: 408–413.  
doi:10.1002/aoc.1631 
[31]  Vanparia SF, Patel TS, Sojitra NA, Jagani CL, Dixit BC, Patel PS, Dixit RB.  
Synthesis, Characterization and Antimicrobial Study of Novel  
4-{[(8-Hydroxyquinolin-5-yl)methyl]amino}benzenesulfonamide and Its Oxinates.  
Acta Chim Slov. 2010; 57: 660–667. 
[32]  Pelczar MJ, Reid RD, Chan ECS.  
Microbiology, 4th ed.  
Tata McGraw–Hill: New Delhi, 1979. 
[33]  Sullivan BP, Salmon DJ, Meyer TJ.  
Mixed phosphine 2,2’-bipyridine complexes of ruthenium.  
Inorg Chem. 1978; 17: 3334–3341.  
doi:10.1021/ic50190a006 
[34]  Zsila F, Bikadi Z, Simonyi M.  
Circular dichroism spectroscopic studies reveal pH dependent binding of curcumin in the minor groove 
of natural and synthetic nucleic acids.  
Org Biomol Chem. 2004; 2: 2902–2910.  
doi:10.1039/b409724f 
[35]  Pansuriya PB, Patel MN.  
DNA-binding, antibacterial and spectral investigations of drug-Fe(II) complexes.  
Appl Organometal Chem. 2007; 21: 926–934.  
doi:10.1002/aoc.1321 308  R. B. Dixit et al.:  
Sci Pharm. 2011; 79: 293–308 
[36]  Pansuriya PB, Dhandhukia P, Thakkar V, Patel MN.  
Synthesis, spectroscopic and biological aspects of iron(II) complexes.  
J Enz Inhib Med Chem. 2007; 22: 477–487.  
doi:10.1080/14756360701228988 
[37] Sathish  NK,  Rajendraprasad VVS, Raghavendra NM, Shanta kumar SM, Mayur YC. 
Synthesis of Novel 1,3-Diacetoxy-Acridones as Cytotoxic Agents and their DNA-Binding Studies. 
Sci Pharm. 2009; 77; 19–32. 
doi:10.3797/scipharm.0811-03 
[38]  Barton JK, Danishefsky AT, Goldberg JM.  
Tris(phenanthroline)ruthenium(II): stereoselectivity in binding to DNA.  
J Am Chem Soc. 1984; 106: 2172–2176.  
doi:10.1021/ja00319a043 
[39]  Lu HL, Liang JJ, Zeng ZZ, Xi PX, Liu XH, Chen FJ, Xu ZH.  
Three salicylaldehyde derivative Schiff base Zn
II complexes: synthesis, DNA binding and hydroxyl 
radical scavenging capacity.  
Trans Metal Chem. 2007; 32: 564–569.  
doi:10.1007/s11243-007-0202-x 